Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

What Is The Role Of The FDA In Measures Taken By Hawaii Officials Against A CBD Company?

The Hawaii Department of Health (DOH) and Hawaii Department of Public Safety (PSD) conducted operations to execute search warrants and to embargo products at several retail stores including a CBD dispensary in Honolulu, reported

Benzinga

Tesla, Ra Medical Systems And 51 Stocks Moving In Tuesday's Mid-Day Session

Gainers Ra Medical Systems, Inc. (NASDAQ: RMED) shares jumped 69.6% to $0.5240 after the company announced it has received FDA 510(k) clearance for its DABRA 2.0 catheter.

Benzinga

Why Precigen Shares Are Gaining Today

Precigen Inc (NASDAQ:PGEN) has agreed to sell its subsidiary Trans Ova Genetics, an animal reproductive technologies company, to URUS, a holding company with cooperative and private ownership. The deal consideration includes $170 million in upfront cash and up to $10 million earn-out based on the performance of Trans Ova in 2022 and 2023. …

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Dyne's Shares Gain After FDA Removed Clinical Hold On Muscular Disease Study

Dyne Therapeutics (NASDAQ: DYN) announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold and cleared its Investigational New Drug (IND) application to initiate a clinical trial of its drug DYNE-25.

Benzinga

What's Going On With Dyne Therapeutics Shares Today?

Dyne Therapeutics Inc (NASDAQ: DYN) shares are trading lower by 5.42% to $6.81 after the company announced FDA clearance of its Investigational New Drug application for DYNE-251 for the treatment of Duchenne muscular dystrophy.

Benzinga

Titan Pharmaceuticals Gets FDA Clearance To Commence Opioid Disorder Study

The U.S. Food and Drug Administration (FDA) has cleared Titan Pharmaceuticals’ (NASDAQ: TTNP) Investigational New Drug (IND) application for the Phase 1 study of its drug candidate Nalmefene.

Benzinga

Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Jul. 5, 2022: RMED, RBCN, LEVI, DAL, TSM

Today's 5 Stock Ideas: Ra Medical Systems (RMED) - Shares up 55.5% premarket. The company announced it has received FDA 510(k) clearance for its DABRA 2.0 catheter. Rubicon Technology (RBCN) - Shares up

Benzinga

Read news from The Economist, FT, and more,
with one subscription

How Pfizer won the pandemic, reaping outsize profit and influence

The grinding two-plus years of the pandemic have yielded outsize benefits for one company — Pfizer — making it both highly influential and hugely profitable as COVID-19 continues to infect tens of thousands of people and kill hundreds each day.

Tribune News Service

40 tonnes of drugs to go up in smoke this week

The Food and Drug Administration (FDA) and narcotics suppression authorities on Monday inspected more than 40 tonnes of confiscated illegal drugs worth over 34.6 billion baht before they are incinerated at a designated facility this week.

Bangkok Post

Parliament an unsafe workplace due to sexual misconduct by MPs, say unions

Political parties cannot be trusted to deal with misbehaviour by their own MPs, claim general secretaries

The Guardian - UK

Sales of Covid self-test kits rise, but Food and Drugs Administration says not enough manpower to track results

PUNE: The demand for Covid self-test kits is rising drastically. Citing that sales are up by at least 10%, the Pune District Chemists Association has instructed members to keep a tab on such transactions.

The Times of India

Medication abortion is common; here's how it works

Medication abortions were the preferred method for ending pregnancy in the U.S. even before the Supreme Court overturned Roe v. Wade

The Independent UK

News briefs

White House touts abortion pill as answer to Roe reversal but FDA rules limit use

Tribune News Service

HC Wainwright Finds 'Synergies In Treatment' For This Bipolar-Focused Stock

HC Wainwright initiated coverage on NRx Pharmaceuticals Inc (NASDAQ:NRXP) with a Buying rating and a price target of $2. Earlier today, the FDA declined to issue an Emergency Use Authorization for NRx's Zyesami for a subgroup of patients who also received Gilead Sciences Inc's (NASDAQ:GILD) remdesivir in addition to Zyesami. The analyst is bullish on: Significant potential for NRX-101 for…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Al Jazeera

US conservatives vow harsh restrictions to curtail abortion pills

Discreet and available by mail, abortion-inducing pills could make conservative abortion bans challenging to enforce.

Reason

Updating Coronavirus Vaccines Is Good, But a Universal Coronavirus Vaccine Would Be Better

Time for a new Operation Warp Speed?

Benzinga

The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

FDA Turns Down NRx Pharmaceuticals' Emergency Use Submission For Covid-19 Candidate

The U.S.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

FDA Expert Panel Favors COVID-19 Boosters Targeting Omicron BA.4, BA.5 Subvariants

The FDA's independent experts voted to include a SARS-CoV-2 omicron component in COVID-19 vaccines that would be used for boosters in the U.S. beginning in fall 2022. The panel has advised manufacturers to develop modified vaccines that add an omicron BA.4/5 spike protein component to the current vaccine composition to create a…

Reason

Review: How Melatonin-Filled 'Lazy Cakes' Became the Subject of a Moral Panic

Senators asked for an investigation since the "sweet, chocolaty taste may encourage consumers to eat well over a recommended quantity of melatonin."

Benzinga

Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates

The biotech sector is poised to end June on a positive note, despite largely disappointing regulatory decisions scheduled during the month, thanks to a reversal in broader market sentiment.

Tribune News Service

Ask the Pediatrician: How do I know these unfamiliar brands of infant formula on store shelves are safe?

Q: Why am I seeing brands of baby formula I’ve never heard of, and are they safe?

Tribune News Service

White House touts abortion pill as answer to Roe reversal but FDA rules limit use

The Biden administration says it’s taking steps to increase access to medication abortion in response to the Supreme Court decision to reverse Roe v. Wade, but some of the administration’s own policies stand in the way of people trying to get the drug.

The Conversation

The Supreme Court has curtailed EPA's power to regulate carbon pollution – and sent a warning to other regulators

In a highly anticipated but not unexpected 6-3 decision, the Supreme Court ruled on June 30, 2022, that the Obama administration’s Clean Power Plan exceeded the U.S. Environmental Protection Agency’s authority under the Clean Air Act.

Benzinga

New Restrictions On Synthetic Marijuana: Harm To The Cannabis Industry?

Beginning July 1, the Oregon Liquor and Cannabis Commission (OLCC) will be restricting the sale of some artificially derived synthetic cannabinoids in the state, reported the Oregonian.

1 … 202 203 204 205

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.